Actively Recruiting
PT-STRESS Study: Predicting Treatment Success and Dealing With Non-response in the Treatment of PTSD
Led by University of Groningen · Updated on 2024-02-28
442
Participants Needed
1
Research Sites
452 weeks
Total Duration
On this page
Sponsors
U
University of Groningen
Lead Sponsor
D
Dimence
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to increase understanding of the effectiveness and efficiency of psychological treatment for adult patients with posttraumatic stress disorder -PTSD- and to make it more personalized. Key questions: 1. Which predictors of treatment success influence treatment outcome of patients with PTSD who receive the three psychotherapeutic treatments investigated in this study? 2. Which specific moderators can be identified with regard to the different psychotherapies (Eye Movement Desensitization and Reprocessing -EMDR-; Prolonged Exposure -PE-; and Interpersonal Psychotherapy -IPT- in the second phase)? 3. In patients with PTSD, does offering another proven effective form of trauma-focused psychotherapy (PE after EMDR, or EMDR after PE) improve symptoms following insufficient response to a first trauma-focused treatment? 4. Is switching from a trauma-focused therapy to a non-trauma-focused treatment (IPT) a more effective strategy for dealing with non-response to a first proven effective psychotherapeutic treatment compared to switching to another trauma-focused therapy? 5. Are there differences in treatment tolerance and differences in dropout rates between PE, EMDR and IPT? Secondary goals: * Investigating the extent to which therapist allegiance to a specific therapy method affects outcomes; * Investigating whether the quality of therapy implementation or the treatment integrity ('adherence/ competence') affects treatment outcomes; * Investigating how much the quality of the therapeutic alliance influences outcomes. Participants receive treatment and will complete questionnaires. The study is conducted in two phases. Its aim is to compare two different trauma-focused treatments (EMDR and PE) for patients with PTSD to one another and with a nontrauma-focused psychotherapy (IPT) and to investigate possible predictors and moderators for treatment success. Patients will first be randomized to PE or EMDR in the first treatment phase. After this first phase, non-responders are re-randomized for a second phase of treatment. They receive either the alternative phase 1 trauma-focused psychotherapy or IPT as non-trauma-focused therapy. In phase 1 researchers will compare the PE and EMDR group to see which treatment is most effective for whom. In phase 2 researchers will compare the trauma-focused treatments (PE and EMDR group) with the nontrauma-focused treatment (IPT group) to see which treatment is most effective for whom.
CONDITIONS
Official Title
PT-STRESS Study: Predicting Treatment Success and Dealing With Non-response in the Treatment of PTSD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults between 18 and 65 years old with a primary diagnosis of PTSD based on DSM-5 criteria
- Willing to participate and provide informed consent
You will not qualify if you...
- Insufficient proficiency in the Dutch language
- Inability to follow the treatment protocol (e.g., due to prolonged absence)
- Unstable medication use or planned changes during treatment unless medically necessary
- Prior evidence-based trauma-focused PTSD treatment in the past year for sufficient duration
- Serious suicidality requiring acute intervention
- Intellectual disability
- Serious addiction as a comorbid condition
- Acute mania or psychotic state
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dimence
Deventer, Netherlands
Actively Recruiting
Research Team
M
Maarten K van Dijk, PhD
CONTACT
D
Dominique Jonkers, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here